View original post here: MediciNova Announces Abstract Regarding MN-166 (ibudilast) in Glioblastoma Accepted for Presentation at the Annual Meeting of the Society for...
View original post here: MediciNova Announces Abstract Regarding MN-166 (ibudilast) in Glioblastoma Accepted for Presentation at the Annual Meeting of the Society for...
Read the original here: Novartis issues EGM Invitation and Shareholder Information Brochure. Sandoz publishes Listing Prospectus ahead of proposed Spin-off vote
View original post here: European Commission Approves Reduced Dosing Frequency for Janssen’s Bispecific Antibody TECVAYLI®▼ (teclistamab)
Originally posted here: Lowell Farms Inc. Announces Unaudited Second Quarter 2023 Financial and Operational Results
Originally posted here: Oxurion Receives Funding of EUR One Million under Atlas Special Opportunities LLC (Atlas) Funding Program
See the original post: Yield10 Bioscience to Announce Second Quarter 2023 Financial Results and Host a Conference Call on Monday, August 14, 2023
See the original post: Novartis Completes Acquisition of Chinook Therapeutics
See original here: Fresh Tracks Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
Go here to read the rest: Rani Therapeutics Reports Second Quarter 2023 Financial Results; Provides Corporate Update
Recent Comments